The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial (Q92862979)
Jump to navigation
Jump to search
scientific article published on 31 May 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial |
scientific article published on 31 May 2019 |
Statements
The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial (English)
Donald T Weed
Serena Zilio
Isildinha M Reis
Zoukaa Sargi
Marianne Abouyared
Carmen R Gomez-Fernandez
Francisco J Civantos
Carla P Rodriguez
1 reference